In Treatment of Gastroesophageal reflux disease (Acid reflux) Gastroesophageal reflux disease (GERD) is a chronic (long-term) condition in which there is an excess production of acid in the stomach. Ponru D 30mg/40mg Capsule SR reduces the amount of acid your stomach makes and relieves the pain associated with heartburn and acid reflux. You should take it exactly as it is prescribed for it to be effective. Some simple lifestyle changes can help reduce the symptoms of GERD. Think about what foods trigger heartburn and try to avoid them; eat smaller, more frequent meals; try to lose weight if you are overweight, and try to find ways to relax. Do not eat within 3-4 hours of going to bed. In Treatment of Peptic ulcer disease Peptic ulcer disease is a condition in which painful sores or ulcers develop in the inner lining of the stomach or gut (intestine). Ponru D 30mg/40mg Capsule SR reduces the amount of acid your stomach makes which prevents further damage to the ulcer as it heals naturally. You may be given other medicines along with this medicine depending on what caused the ulcer. You need to keep taking the medicine as it is prescribed for it to be effective, even if the symptoms seem to disappear.
Caution is advised when consuming alcohol with Ponru D 30mg/40mg Capsule SR. Please consult your doctor.
Ponru D 30mg/40mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ponru D 30mg/40mg Capsule SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Ponru D 30mg/40mg Capsule SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Ponru D 30mg/40mg Capsule SR should be used with caution in patients with kidney disease. Dose adjustment of Ponru D 30mg/40mg Capsule SR may be needed. Please consult your doctor.
Ponru D 30mg/40mg Capsule SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Ponru D 30mg/40mg Capsule SR may not be needed in these patients. Please consult your doctor.
If you miss a dose of Ponru D 30mg/40mg Capsule SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cmg Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Being Care Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Adjener Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Raksh Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Deserve Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Carexia Healthcare LLP || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fascin Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vidakem Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenon Healthcare || ₹14.5/tablet (25% cheaper)